Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1935 of 6351
-
New drug combo shows promise in slowing rare sarcoma growth
Disease control CompletedMulticenter, prospective, open-labeled, 2-arm, non-comparative randomized phase II trial to assess the antitumor activity of berzosertib in association with gemcitabine
Phase 2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Brain zapping with light: a new hope for attention problems?
Symptom relief Recruiting nowInattentiveness and impulsivity in healthy adults and individuals with attention deficit hyperactivity disorder (ADHD) diminish these individuals' quality of life. Cortical hypometabolism has been hypothesized to contribute to inattentiveness in ADHD. Transcranial photobiomodulat…
Sponsor: Francisco Gonzalez-Lima, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control CompletedThis phase I trial finds the best dose and side effects of cabozantinib and pamiparib in treating patients with solid tumors that have spread to other places in the body (advanced) or does not respond to treatment (refractory). Cabozantinib and pamiparib may stop the growth of tu…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Supercharged immune cells take on incurable tumors
Disease control OngoingThis is a phase I/Ib study of adoptively transferred T-cell receptor gene-engineered T cells (TCR-T) targeting tumor-specific antigens, with in vivo CD40 activation and PD-1 blockade, for patients with incurable cancers. The study design is a safety lead-in TCR-T with CD40/PD-1 (…
Phase 1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for kidney cancer patients who Can't have surgery: targeted radiation trial launches
Disease control Recruiting nowThis is a multicenter, single arm phase II study of stereotactic body radiation therapy (SBRT) for patients with medically inoperable primary renal cell carcinoma (RCC).
Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Spinal stimulation without tingling: a new hope for failed back surgery pain?
Disease control OngoingGiven the substantial socioeconomic impact of Spinal Cord Stimulation (SCS) implantations and given that currently no direct high-quality evidence with a relevant outcome measurement is available to guide the treatment choice between subthreshold SCS versus best medical treatment…
Sponsor: Moens Maarten • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Brief therapy aims to stop PTSD before it starts in spinal cord injury patients
Symptom relief By invitation onlyThis study will examine the use brief prolonged exposure (Brief PE) therapy compared to standard clinical care to reduce posttraumatic distress among people who have had a spinal cord injury and are receiving rehabilitation in an inpatient setting.
Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can a common MS drug slow blindness in AMD?
Disease control Recruiting nowThe primary objectives of the study are to assess the safety, tolerability and evidence of activity of 12 months oral treatment with TEFIDERA® in subjects with Geographic Atrophy associated with Age-Related Macular Degeneration (AMD).
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a nasal spray help Parkinson's? new trial tests insulin and glutathione combo
Disease control Recruiting nowThis study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Phase 2 • Sponsor: Gateway Institute for Brain Research • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
A Doctor's prescription for play: could exercise be the medicine for childhood obesity?
Disease control CompletedBackground: physical inactivity is a main cause of childhood obesity. Physical activity on prescription (PAP) is an evidence-based intervention for adults, but has not been evaluated in children with obesity. Aim: to evaluate the feasibility of a PAP intervention for children wi…
Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Heart attack patients: can a common gout pill improve bypass recovery?
Disease control CompletedThe present study seeks to evaluate the effectiveness of the use of perioperative colchicine with regard to operative complications, in patients with acute coronary syndrome and indication for cardiac post-surgical revascularization. Patients will be selected and randomized whil…
Phase 2 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a Smartphone-Guided exercise program ease the burden of atrial fibrillation?
Disease control CompletedAtrial fibrillation (AF) patients suffer a high symptom burden and reduced quality of life (QoL), high hospitalization rates and few effective treatment options. They have a high burden of cardiovascular risk factors and events. Lifestyle changes and exercise is a cornerstone of …
Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Heart attack drug targets tiny vessels, not blockages
Disease control Recruiting nowPatients with heart attack or heart injury are tested (angiogram) for blockages in their arteries. Patients may develop heart problems caused by damage to small (microvascular) blood vessels. Eplerenone, a mineralocorticoid receptor-selective antagonist, reduces blood vessel inju…
Phase 2 • Sponsor: NHS National Waiting Times Centre Board • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can simple changes close the racial gap in living kidney donation?
Knowledge-focused CompletedWhile many people offer to be evaluated at transplant centers as potential living donors to donate one kidney to someone they know, few ultimately donate. Racial/ethnic minorities are less likely to become living donors. This study examines potentially modifiable factors affectin…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Virtual reality could make head and neck cancer surgery more precise
Knowledge-focused Recruiting nowThis clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary …
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New drug targets Alzheimer's proteins in Early-Onset patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-APP administered by intrathecal (IT) injection in adult patients with early-onset Alzheimer's Disease (EOAD). Maximum trea…
Phase 1 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Promising combo tackles rare sarcoma in early trial
Disease control OngoingThis research study involves the study drug lurbinectedin in combination with doxorubicin. This research has two parts. The first part is being done to determine the tolerability of lurbinectedin with doxorubicin in people with soft tissue sarcoma. The second part is a randomize…
Phase 1/2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Blood thinner breakthrough could stop clots in rare anemia
Prevention Recruiting nowAutoimmune hemolytic anemia (AIHA) is a rare autoimmune disease (incidence \<1/100,000 population) responsible for the destruction of red blood cells by the host immune system, notably through the action of autoantibodies. Apart from complications related to anemia, the occurren…
Phase 2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
New inhaler aims to stop prolonged seizures fast and safely
Symptom relief By invitation onlyThe purpose of the study is to evaluate the long-term safety and tolerability of Staccato alprazolam.
Phase 3 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Could a gene test pick the right blood pressure pill for black patients?
Disease control OngoingLysine specific demethylase-1 (LSD1) is an epigenetic regulator of gene transcription involved in the pathophysiology of elevated blood pressure and likely renal damage in Blacks. This project investigates whether a genetically driven anti-hypertensive approach proves superior in…
Phase 4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC